Sarepta Therapeutics Inc (SRPT)

Gross profit margin

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Gross profit (ttm)	US$ in thousands	873,158	729,906	603,283	545,602	482,099	478,303	466,335	464,632	477,203	414,021	349,721	294,505	266,452	221,562	181,124	136,135	99,683	95,172	96,662	98,492
Revenue (ttm)	US$ in thousands	1,403,300	1,243,336	1,104,982	1,003,434	975,683	933,013	876,047	835,184	765,786	701,887	645,564	600,082	573,356	540,099	495,074	450,191	407,496	380,833	365,135	344,580
Gross profit margin		62.22%	58.71%	54.60%	54.37%	49.41%	51.26%	53.23%	55.63%	62.32%	58.99%	54.17%	49.08%	46.47%	41.02%	36.59%	30.24%	24.46%	24.99%	26.47%	28.58%

March 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $873,158K ÷ $1,403,300K
= 62.22%

Sarepta Therapeutics Inc's gross profit margin has shown fluctuations over the provided periods. The margin ranged from a low of 24.46% in March 2020 to a high of 62.32% in March 2022. Overall, the trend indicates a general improvement in gross profit margin from 2019 to 2022, with a significant increase observed between March 2021 and March 2022. However, there was a slight decline in the margin in recent quarters, dropping from 62.22% in March 2024 to 54.37% in June 2023. This could be an area of concern warranting further investigation to understand the factors driving these fluctuations in the company's profitability.